HAT1 Modulator Screening Using Click-Chemistry Acetyltransferase Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective chemical inhibitors for histone acetyltransferase 1 (HAT1) enzymes, which are associated with cancerous growth and poor outcomes in malignancies, and there is a need for high-throughput assays to identify modulators of acetyltransferase activity.
Innovation Solution
Development of assays using substrates with alkyne handles and click chemistry to label acetyl groups, combined with virtual screening, to identify HAT1 modulators such as agonists and antagonists, and their application in cancer treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods are used to study acetyltransferases, then basic research can be conducted, but effective chemical inhibitors cannot be identified for treating neoplasms
Solution Approach 1:
The patent employs an acetyl-CoA analog with an alkyne handle as an intermediary molecule that mimics the natural substrate but includes a reactive handle for subsequent chemical labeling. This intermediary enables the detection and identification of inhibitors without requiring the inhibitors to be pre-existing, thus resolving the contradiction between treatment effectiveness and inhibitor availability
Solution Approach 2:
The patent replaces traditional biochemical assay methods with a chemical biology approach using click chemistry. Instead of relying on complex protein-protein interaction assays, the method uses copper-catalyzed azide-alkyne cycloaddition to label acetylated substrates, providing a simpler and more effective way to identify inhibitors
2Measurement precision
If traditional assay methods are used, then acetyltransferase activity can be measured, but modulators cannot be effectively identified
Solution Approach 1:
The patent substitutes complex traditional biochemical detection methods with click chemistry followed by biotin-streptavidin binding and fluorescent detection. This replacement simplifies the assay by using well-established, high-affinity molecular interactions and standard fluorescent microscopy or flow cytometry techniques
Solution Approach 2:
The patent changes the detection parameter from measuring direct enzymatic activity to measuring the presence of acetylated substrates through chemical labeling. This parameter change enables the use of fluorescent markers and standard imaging equipment, reducing assay complexity while maintaining measurement precision
3Reliability
If HAT1 activity is not modulated, then normal cellular function is maintained, but cancer progression cannot be inhibited
Solution Approach 1:
The patent extracts and isolates the specific function of HAT1 in EGF-dependent cancer proliferation by using acetyl-CoA analogs that specifically label HAT1 substrates. This extraction allows for the selective identification of HAT1 inhibitors that can block cancer progression without broadly affecting all acetyltransferase activities
Solution Approach 2:
The patent uses acetyl-CoA analogs as copies of the natural substrate that include additional functional handles. These analog copies enable the specific tracking and inhibition of HAT1 activity in cancer cells while maintaining the ability to distinguish HAT1-specific effects from general acetylation effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Identifies potent HAT1 modulators like nogalarol and other compounds that inhibit HAT1 activity, effectively reducing cancerous growth and improving patient outcomes by targeting HAT1-stimulated proliferation.
Implementation Method 1
An acetyltransferase, a donor molecule having an acetyl-like group with an alkyne handle, and a modulator are added to the substrate such that the acetyltransferase is capable of transferring the acetyl-like group with the alkyne handle of the donor molecule onto the available functional groups of the substrate. Biotin-azide is added to the substrate such that the azide group is capable of conjugating to the acetyl-like groups with alkyne handle
Implementation Method 2
A reporter molecule conjugated with streptavidin is added to the substrate such that the reporter molecule binds to the biotin that is extended from the acetyl-like groups
Data Source
AI summary
Methods to identify modulators of histone acetyltransferases are described. Modulators of histone acetyltransferases can be used to treat individuals. In some instances, modulators of histone acetyltransferases are utilized to treat individuals having a neoplasm.